Benzinga | May 13, 2021 04:12PM EDT

Applied DNA Sciences Q2 EPS $(0.21), Inline, Sales $2.70M Beat $2.60M Estimate

Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.21) per share which met the analyst consensus estimate. This is a 73.42 percent increase over losses of $(0.79) per share from the same period last year. The company reported quarterly sales of $2.70 million which beat the analyst consensus estimate of $2.60 million by 3.85 percent. This is a 388.71 percent increase over sales of $552.47 thousand the same period last year.